Return to Polyphenon Pharmasitemap
 
  homeabout Polyphenon Pharmaresearch & developmentpartnering opportunitiesinvestor relationscontact us  
   
 
   

[ newsroom ]


Media Inquiries
Email
 

 

 

   


SEPTEMBER 09, 2009
MediGene AG Receives Marketing Authorization for Veregen® in Germany

JUNE 22, 2009
Polyphenon E May Affect Prostate Cancer Progression

MAY 26, 2009
Polyphenon E Shows Promise in Leukemia Trials

MAY 15, 2009
Polyphenon Pharma featured in Genetic Engineering & Biotechnology News article

MARCH 13, 2009
Polyphenon Pharma to Present at the 2009 BIO-Europe Spring Conference  
 

JULY 28, 2008
Polyphenon Pharma Receives Orphan Drug Designation for Its Botanical Drug, Polyphenon E, for the Treatment of CLL

Legal Notices and Privacy Policy

Copyright © 2007-2009. Polyphenon Pharma
All Rights Reserved.
09-Sep-2009 12:38:30 PM

Polyphenon Pharma
655 Third Avenue Suite 1804
New York, NY 10017